NCT04062565View on ClinicalTrials.gov

Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH

PHASE3RecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

March 25, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG

Treprostinil Injectable Product

Injection

DRUG

Riociguat Pill

Tablet

Trial Locations (1)

85724

RECRUITING

University of Arizona, Tucson

All Listed Sponsors

lead

University of Arizona

OTHER